Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Human Cancer Biology

Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis

Pingyu Zhang, Yanwen Yang, Patrick A. Zweidler-McKay and Dennis P.M. Hughes
Pingyu Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanwen Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick A. Zweidler-McKay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis P.M. Hughes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-07-1992 Published May 2008
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Notch and HES1 expression are correlated with metastatic phenotype in osteosarcoma cells and tumors of osteosarcoma patients. A, reverse transcription–PCR analysis of Notch pathway genes (ligand DLL1, receptors Notch1-Notch4, and downstream targets HES1, HES5, HERP2 and DTX1) in normal human osteoblast cells (hOSB), four human osteosarcoma cells, and two metastatic osteosarcoma tumor specimens (1 and 2). OS187 and COL are primary metastatic osteosarcoma cell lines. SAOS2 is a nonmetastatic osteosarcoma cell line, and LM7 is a metastatic subline of SAOS2. B, top, real-time PCR quantification of Notch1, Notch2, and HES1 in human osteoblastic and osteosarcoma cells. All Ct values of osteosarcoma cell lines are normalized to actin first. Comparison is made to the human normal osteoblast sample, which is defined as a relative expression of 1. Bottom, gel image shows the quantitative product of the PCR reaction.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Effects of GSI on the cell proliferation and in vitro invasiveness of osteosarcoma cells. A, Notch signaling inhibition by GSI at the indicated concentrations was inferred by HES1 expression at mRNA and protein level. OS187 cells were cultured with GSI for 48 h. B, Matrigel transwell assay of OS187 cells (5 × 104 cells per well) treated by GSI. Histograms depict the mean number of transmigrated cells at 48 h from three wells for each treatment. Invasion of OS187 cells was decreased significantly by GSI at 0.1, 0.3, and 1 nmol/L concentration (**, P < 0.005). C, Matrigel transwell assay of SAOS2 (5 × 104 per well) and LM7 cells (5 × 104 per well) with GSI treatment. LM7 cells showed higher invasive ability than SAOS2 cells (**, P < 0.005), and in vitro invasiveness of LM7 cells was significantly reduced by GSI at 0.1, 0.3, and 1 nmol/L (**, P < 0.005). Top, histogram depicts quantified invasiveness as in B; bottom, gel depicts reverse transcription–PCR analysis of HES1 and actin expression in LM7 cells treated with GSI, suggesting the inhibition of Notch signaling. D, in vitro invasion assay of COL cells with GSI treatment. Data are depicted as in C. Invasiveness and HES1 expression of COL cells were not affected by GSI.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Effects of manipulation of Notch signaling on osteosarcoma invasiveness in vitro. A-C, top, relative invasiveness in vitro of OS187 cells (1 × 104 per well; A), SAOS2 cells (1.5 × 105 per well; B), and LM7 cells (5 × 104 per well; C) transduced with ICN1, dnMAM, or HES1. Note: the input of cells for each cell line was adjusted to give roughly equal number of invading cells for each vector control sample. Histograms depict the quantified invasiveness. **, P < 0.005; *, P < 0.05. Bottom, gel depicts PCR analysis of HES1 and actin in the transduced cells.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Effects of GSI (1 nmol/L) on in vitro invasiveness of OS187 cells transduced with empty vector, ICN1 (*, P < 0.05), and HES1 (*, P < 0.05). GSI (1 nmol/L) significantly suppressed invasion of OS187 cells transduced with empty vector. However, OS187 cells transduced with ICN1 (A) or HES1 (B) are resistant to GSI treatment. Data are displayed as in Fig. 2C.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Effects of manipulation of Notch signaling on osteosarcoma invasiveness and metastasis in vivo. A and B, representative X-ray images (left) show the osteolytic lesion in the primary tumor site (tibia) of both vector and dnMAM group. Two representative images (right, 40×; left, 400×) show the H&E staining of orthotopic bone tumor (top two) and lung metastasis (bottom two) in vector (A) and dnMAM (B) groups. C, average tibial tumor volume of the OS187 orthotopic osteosarcoma xenograft model using cells transduced with dnMAM or empty vector as control. A representative experiment of three is shown. D, the average number of metastatic foci formed in lung tissues of vector and dnMAM groups is indicated. **, P < 0.005; n = 3 per group in each experiment. All tumor clusters with >10 cells were counted as micrometastases.

Additional Files

  • Figures
  • Supplementary Data

    Files in this Data Supplement:

    • Supplementary Figures 1-5, Table 1 - PDF file - 51K
    • Supplementary Figure Legends 1-5, Table Legend - PDF file - 27K
PreviousNext
Back to top
Clinical Cancer Research: 14 (10)
May 2008
Volume 14, Issue 10
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis
Pingyu Zhang, Yanwen Yang, Patrick A. Zweidler-McKay and Dennis P.M. Hughes
Clin Cancer Res May 15 2008 (14) (10) 2962-2969; DOI: 10.1158/1078-0432.CCR-07-1992

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis
Pingyu Zhang, Yanwen Yang, Patrick A. Zweidler-McKay and Dennis P.M. Hughes
Clin Cancer Res May 15 2008 (14) (10) 2962-2969; DOI: 10.1158/1078-0432.CCR-07-1992
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • MET in Papillary RCC
  • Identification of T-cell Antigens by Minigene Screening
  • Sirt7 Promotes Colorectal Cancer Tumorigenesis
Show more Human Cancer Biology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement